Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis

Peritoneal Dialysis International

Volumn 19, Issue 6, 1999, Pages 550-555

  Bayston, Roger ^a,b   Andrews, Mark ^b   Rigg, Keith ^b   Shelton, Andrew ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Catheter loss; Cuff infection; Peritonitis; Relapse; Treatment

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; FLUCLOXACILLIN; VANCOMYCIN;

ARTICLE; CATHETER INFECTION; CONTAMINATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; PERITONEAL CAVITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0033394646     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900610     Document Type: Article

References (17)

1. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD viability: a long-term comparison with hemodialysis. Perit Dial Int 1996; 16:276-87.
2. Digenis GE, Abraham G, Savin E, Blake P, Dombros N, Sombolos K, et al. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1990; 10:45-7.
3. Tzamaloukas AH, Murata GH, Fox L. Peritoneal catheter loss and death in continuous ambulatory peritoneal dialysis peritonitis: correlation with clinical and biochemical parameters. Perit Dial Int 1993; 13(Suppl 2):S338-40.
4. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17:360-4.
5. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
6. Hasbargen BJ, Rodgers DJ, Hasbargen JA, Quinn MJ, James MK. Exit-site care - is it time for a change? Perit Dial Int 1993; 13(Suppl 2):S313-15.
7. Bunke CM, Brier ME, Golper TA. Pseudomonas peritonitis in peritoneal dialysis patients: the Network 9 peritonitis study. Am J Kidney Dis 1995; 25:774-96.
8. Golper TA, Brier ME, Bunke CM, Schreiber MJ, Bartlett DK, Hamilton RW, et al. Risk factors for peritonitis in chronic peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Am J Kidney Dis 1996; 28:428-36.
9. Gokal R, Ash SR, Helfrich BG, Holmes CJ, Joffe P, Nichols W, et al. Peritoneal catheters and exit-site practices: toward an optimum peritoneal access. Perit Dial Int 1993; 13:29-39.
10. Gokal R, Alexander S, Ash S, Chen TW, Danielson A, Holmes C, et al. Peritoneal catheters and exit-site practices: toward an optimum peritoneal access: 1998 update. Perit Dial Int 1998; 18:11-33.
11. Report of a Working Party of the British Society for Antimicrobial Chemotherapy. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; i:845-8.
12. Gupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996; 28:415-19.
13. Korzets Z, Erdberg A, Golan E, Ben-Chitrit S, Verner M, Rathus V, et al. Frequent involvement of the internal cuff segment in CAPD peritonitis and exit-site infection - an ultrasound study. Nephrol Dial Transplant 1996; 11:336-9.
14. Marrie TJ, Noble M, Costerton JW. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol 1983; 18:1388-98.
15. Dasgupta MK, Bettcher KB, Ulan RA, Burns V, Lam K, Dossetor JB, et al. Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 1987; 7:168-73.
16. Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19:65-70.
17. Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1982; 21:373-80.